Correspondence 0001193125-24-025284 from VivoSim Labs, INC. (VIVS)
VivoSim Labs, INC.
Date: Feb. 6, 2024 · CIK: 0001497253 · Accession: 0001193125-24-025284
AI Filing Summary & Sentiment
File numbers found in text: 333-276722
Show Raw Text
CORRESP 1 filename1.htm CORRESP Organovo Holdings, Inc. Sorrento Valley Road, Suite 100 San Diego, California 92121 February 6, 2024 VIA EDGAR Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549-0406 Re: Organovo Holdings, Inc. Registration Statement on Form S-3, Filed January 26, 2024 File No. 333-276722 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Organovo Holdings, Inc. (the “Company”) hereby requests that the effectiveness of the Registration Statement on Form S-3 (Registration No. 333-276722) of the Company (the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) on January 26, 2024, be accelerated so that such Registration Statement shall become effective at 4:30 p.m. (Eastern Time) on February 8, 2024, or as soon as possible thereafter. It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Samantha H. Eldredge of Paul Hastings LLP, by telephone at (650) 320-1838 or by email at samanthaeldredge@paulhastings.com. The Company hereby authorizes Ms. Eldredge to orally modify or withdraw this request for acceleration. Sincerely, ORGANOVO HOLDINGS, INC. By: /s/ Keith Murphy Keith Murphy Executive Chairman cc: Samantha H. Eldredge, Esq., Paul Hastings LLP